Celiac Disease

IBS vs Celiac Disease: The Autoimmune Condition That Mimics IBS in Millions

Celiac disease affects approximately 1 in 100 people worldwide, but up to 83 percent remain undiagnosed. The symptoms, including bloating, diarrhea, constipation, abdominal pain, and fatigue, overlap almost entirely with IBS. The critical difference is that celiac causes measurable intestinal damage and has a definitive blood test. If you have never been screened, it takes one blood draw to rule it out.

Last updated 2026-04-25

Current Consensus

  • Celiac disease prevalence is approximately 1 percent globally, with up to 83 percent of cases undiagnosed (Rubio-Tapia et al., 2012).
  • Tissue transglutaminase IgA (tTG-IgA) antibody testing is the recommended first-line screening test with sensitivity above 95 percent.
  • Celiac disease causes villous atrophy in the small intestine, which is absent in IBS and can be confirmed by duodenal biopsy.
  • Patients must be consuming gluten for at least 6 weeks before testing to avoid false negatives.
  • First-degree relatives of celiac patients have a 10 to 15 percent prevalence, warranting screening even without symptoms.

Open Questions

  • Whether non-celiac gluten sensitivity is a distinct entity or a collection of other conditions including undiagnosed celiac, wheat allergy, and FODMAP sensitivity.
  • The optimal approach to seronegative celiac disease, where antibodies are negative but biopsy shows villous atrophy.
  • Whether a gluten-free diet improves symptoms in IBS patients without celiac disease, and if so, through what mechanism.
  • Long-term outcomes of patients with potential celiac disease (positive antibodies, normal biopsy).
  • The role of environmental triggers beyond gluten in celiac disease onset.

Not sure if this applies to you?

Our misdiagnosis quiz evaluates your symptoms against 14 conditions commonly confused with IBS.

Take the Quiz

Medical Disclaimer: The content in this section is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making changes to your health regimen. GLP1Gut is a tracking tool, not a medical device.